Dark

Check out our Dark Pool Levels

EMED
ELECTROMEDICAL TECH INC
stock OTC

EOD

Aug 7, 2026

0.000100USD0.000%(0.000000)201,711

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 13, 2022

06:01AM EST Electromedical Issues Shareholder Letter from the CEO on the Road Ahead for 2022 PR Newswire

Nov 18, 2021

10:35AM EST Electromedical Technologies, Inc. Reports Third Quarter 2021 Financial Results PR Newswire

Sep 30, 2021

06:01AM EDT Electromedical Technologies Receives Key Medical Device Certification PR Newswire

Aug 19, 2021

11:55AM EDT Electromedical Technologies Clarifies Comparative Six-Month Highlights Reported PR Newswire

Aug 18, 2021

07:56AM EDT Electromedical Technologies Reports Comparative 48% Revenue Growth for June PR Newswire

Jul 29, 2021

06:00AM EDT Electromedical Technologies and Nazarbayev University to Commence GlobeNewswire Inc

Jun 10, 2021

12:09PM EDT Electromedical Technologies Flagship Device to Be Introduced at National PR Newswire

Jun 3, 2021

06:01AM EDT Electromedical Technologies and Nazarbayev University Complete Agreement to PR Newswire

May 25, 2021

08:34AM EDT Electromedical Technologies' New Weekly Marketing Series Launches This Week PR Newswire

May 19, 2021

06:00AM EDT - Event with Dr. Jeff Harper to highlight the benefits of the WellnessProPlus for chronic pain sufferers- Facebook Live Event schedule for TODAY, May 19, 2021 at 2:20 PM CST (12:20pm PST/3:20pm EST)- Online meeting is the first in a series to foster broad awareness and utilization of EMEDs devices GlobeNewswire Inc

May 6, 2021

06:00AM EDT - Company adds New Sales Director with 12 years of Experience Selling and Training the Wellness Pro+ GlobeNewswire Inc

Apr 20, 2021

10:32AM EDT - Efficacy and Product Integration Testing Slated for Completion in Fall 2021 GlobeNewswire Inc

Apr 13, 2021

06:00AM EDT Electromedical Technologies, Inc. (OTCQB: EMED ) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce that CEO Matthew Wolfson has, in recent weeks, been a featured guest on the popular Big Biz Radio Show. The latest interview can be accessed here. GlobeNewswire Inc

Mar 19, 2021

02:27PM EDT Electromedical Technologies, Inc. Issues Statement on Recently GlobeNewswire Inc

Feb 23, 2021

10:31AM EST Electromedical Technologies Secures Funding for Product Expansion PR Newswire

09:48AM EST - Funding earmarked for WellnessPlus POD prototype production and completion-Prototype to be used for future FDA 510(k) submission-Company on track for late 2021 FDA filing GlobeNewswire Inc

Dec 15, 2020

06:00AM EST Electromedicals Annual Cyber Sale of Flagship GlobeNewswire Inc

Dec 7, 2020

06:00AM EST -- High profile firm WireBuzz boasts relationships with Fortune 500 firms and nations top health care companies -- Industry leading digital marketing agency renowned for driving awareness and online business -- WireBuzz poised to aid Electromedical Technologies in onboarding new distributors and customers GlobeNewswire Inc

Nov 19, 2020

06:00AM EST - Company completes production of 1,200FDA-cleared WellnessPro+ devices GlobeNewswire Inc

Nov 4, 2020

06:00AM EST Electromedical Technologies, Inc. and Energetic Wellness School of GlobeNewswire Inc

Oct 7, 2020

06:00AM EDT Electromedical Technologies Announces Uplisting to the OTCQB Market GlobeNewswire Inc

Sep 15, 2020

08:00AM EDT Electromedical Technologies, Inc. (OTCMKTS:EMED) (the Company), a pioneer in the development and manufacturing of bioelectronic devices, is pleased to announce that it continues to find strong interest for its FDA cleared WellnessPro+ device line as a bioelectronic chronic pain solution from top professional athletes in the NBA, NFL, NHL, PGA, and PBR. GlobeNewswire Inc

Sep 11, 2020

10:58AM EDT Electromedical Technologies Announces on boarding of In-House GlobeNewswire Inc

Sep 4, 2020

06:00AM EDT Electromedical Technologies Receives FINRA Approval for New GlobeNewswire Inc

Share